Scientific paper - Original scientific paper
Best practices for long-term monitoring and follow-up of Alemtuzumab-Treated MS patients in real-world clinical settings
Frontiers in Neurology, 10 (2019); https://doi.org/10.3389/fneur.2019.00253

Barclay, Krista; Carruthers, Robert; Traboulsee, Anthony; Bass, Ann D.; LaGanke, Christopher; Bertolotto, Antonio; Boster, Aaron; Celius, Elisabeth G.; Seze, Jérôme de; Cruz, Dionisio Dela; Habek, Mario; Lee, Jong-Mi; Limmroth, Volker; Meuth, Sven G.; Oreja-Guevara, Celia; Pagnotta, Patricia; Vos, Cindy; Ziemssen, Tjalf; Baker, Darren P.; Wijmeersch, Bart Van More authors...

Cite this document

Barclay, K., Carruthers, R., Traboulsee, A., Bass, A. D., LaGanke, C., Bertolotto, A. ... Wijmeersch, B. V. (2019). Best practices for long-term monitoring and follow-up of Alemtuzumab-Treated MS patients in real-world clinical settings. Frontiers in Neurology, 10.. doi: 10.3389/fneur.2019.00253

Barclay, Krista, et al. "Best practices for long-term monitoring and follow-up of Alemtuzumab-Treated MS patients in real-world clinical settings." Frontiers in Neurology, vol. 10, 2019. https://doi.org/10.3389/fneur.2019.00253

Barclay, Krista, Robert Carruthers, Anthony Traboulsee, Ann D. Bass, Christopher LaGanke, Antonio Bertolotto, Aaron Boster, et al. "Best practices for long-term monitoring and follow-up of Alemtuzumab-Treated MS patients in real-world clinical settings." Frontiers in Neurology 10 (2019). https://doi.org/10.3389/fneur.2019.00253

Barclay, K., et al. (2019) 'Best practices for long-term monitoring and follow-up of Alemtuzumab-Treated MS patients in real-world clinical settings', Frontiers in Neurology, 10. doi: 10.3389/fneur.2019.00253

Barclay K, Carruthers R, Traboulsee A, Bass AD, LaGanke C, Bertolotto A, and sur.. Best practices for long-term monitoring and follow-up of Alemtuzumab-Treated MS patients in real-world clinical settings. Frontiers in Neurology [Internet]. 2019 March 22 [cited 2024 July 25];10. doi: 10.3389/fneur.2019.00253

K. Barclay, et al., "Best practices for long-term monitoring and follow-up of Alemtuzumab-Treated MS patients in real-world clinical settings", Frontiers in Neurology, vol. 10, March 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:548907. [Accessed: 25 July 2024]

Please login to the repository to save this object to your list.